Knockdown of CDK6 enhances glioma sensitivity to chemotherapy

Knockdown of CDK6 enhances glioma sensitivity to chemotherapy

Item
http://www.wikidata.org/entity/Q28269665
Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureMEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment.miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3pmiR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.Progranulin Deficiency Reduces CDK4/6/pRb Activation and Survival of Human Neuroblastoma SH-SY5Y Cells.Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex.Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?: Brain tumors and microcephaly arise from opposing derangements regulating progenitor growth. Drivers of microcephaly could be attractive brain tumor targets.
P2860

Knockdown of CDK6 enhances glioma sensitivity to chemotherapy

Item
http://www.wikidata.org/entity/Q28269665
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@ast
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@en
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@nl
type
label
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@ast
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@en
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@nl
prefLabel
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@ast
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@en
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921